Tobacco plants could be used as an ingredient in ovarian cancer vaccines

For cancer, active prevention is always more important than treatment after the disease occurs. Recent medical research has found that tobacco plants are also an effective ovarian cancer vaccine . Through the research on ovarian cancer vaccines, it is believed that medical scientists can develop more effective methods to prevent and treat ovarian cancer.

Genetically engineered tobacco plants can be used as a source of proteins that stimulate the production of resistance to human papillomavirus (HPV). HPV is a common cause of cervical cancer. Since HPV is a precursor to cervical cancer, the development of an ovarian cancer vaccine is being considered. But for some reason, HPV grows and reproduces slowly in a normal microbial environment, and the genetic material extracted from HPV can grow in tobacco plants, thereby obtaining viral fragments. Since there is no traditional method to learn from, the work on HPV at Georgetown took a long time, but still failed to obtain enough antibodies for clinical ovarian cancer vaccine experiments. Methods are being developed to obtain large amounts of viral fragments. North Carolina State University provides experts in growing tobacco in this regard. But it may take 2-3 years before clinical trials can be carried out.

The above is the conclusion about ovarian vaccine drawn by medical experts. I believe many friends can’t believe it, but for the research on ovarian cancer vaccine, this research has played a huge role in promoting the medical field.

For more information, please visit the ovarian cancer disease special topic at http://www..com.cn/zhongliu/nc/ or consult an expert for free. The expert will then give a detailed answer based on the patient's specific situation.